Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Funke-Chambour

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Annals of the American Thoracic Society|October 30, 2020
Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?Manuela Funke-Chambour
Therapeutische Umschau. Revue Therapeutique|February 18, 2016
[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]Manuela Funke-Chambour, Thomas Geiser
Respiration; International Review of Thoracic Diseases|November 20, 2018
Antifibrotics: Shrinking the Box of Therapeutic UncertaintySabina A Guler, Manuela Funke-Chambour
Praxis|September 7, 2017
Anke Schertel, Manuela Funke-Chambour, Thomas Geiser
Therapeutische Umschau. Revue Therapeutique|January 9, 2020
[Diagnostics of interstitial lung diseases in the multidisciplinary team]Sabina Berezowska, Alexander Pöllinger, Manuela Funke-Chambour
Der Pathologe|January 30, 2020
[Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course]Stephan C Schäfer, Manuela Funke-Chambour, Sabina Berezowska
JAMA|September 12, 2023
Ziritaxestat and Lung Function in Idiopathic Pulmonary FibrosisLeticia Kawano-Dourado, Manuela Funke-Chambour, Athol U Wells
Respiratory Research|January 28, 2025
Fibrosis in PCLS: comparing TGF-β and fibrotic cocktailCarlos Machahua, Thomas M Marti, Patrick Dorn, et al.
Respiratory Research|November 15, 2017
Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphiesAnke Schertel, Manuela Funke-Chambour, Thomas Geiser, et al.
Der Pathologe|December 21, 2019
[The multidisciplinary discussion-the gold standard in diagnosing interstitial lung diseases]Sabina Berezowska, Manuela Funke-Chambour, Alexander Pöllinger, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Annals of the American Thoracic Society|October 30, 2020
Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?Manuela Funke-Chambour
Therapeutische Umschau. Revue Therapeutique|February 18, 2016
[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]Manuela Funke-Chambour, Thomas Geiser
Respiration; International Review of Thoracic Diseases|November 20, 2018
Antifibrotics: Shrinking the Box of Therapeutic UncertaintySabina A Guler, Manuela Funke-Chambour
Praxis|September 7, 2017
Anke Schertel, Manuela Funke-Chambour, Thomas Geiser
Therapeutische Umschau. Revue Therapeutique|January 9, 2020
[Diagnostics of interstitial lung diseases in the multidisciplinary team]Sabina Berezowska, Alexander Pöllinger, Manuela Funke-Chambour
Der Pathologe|January 30, 2020
[Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course]Stephan C Schäfer, Manuela Funke-Chambour, Sabina Berezowska
JAMA|September 12, 2023
Ziritaxestat and Lung Function in Idiopathic Pulmonary FibrosisLeticia Kawano-Dourado, Manuela Funke-Chambour, Athol U Wells
Respiratory Research|January 28, 2025
Fibrosis in PCLS: comparing TGF-β and fibrotic cocktailCarlos Machahua, Thomas M Marti, Patrick Dorn, et al.
Respiratory Research|November 15, 2017
Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphiesAnke Schertel, Manuela Funke-Chambour, Thomas Geiser, et al.
Der Pathologe|December 21, 2019
[The multidisciplinary discussion-the gold standard in diagnosing interstitial lung diseases]Sabina Berezowska, Manuela Funke-Chambour, Alexander Pöllinger, et al.
Pageof 7